DRAP wants people to report drug unavailibility: ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has actually Sunday paid attention to the abnormalities in drug pricing throughout the country with records of profiteering as well as hoarding of necessary medications as well as has installed a helpline for people to report any upward rate distinction as well as seek information of any kind of sort.
The government medication regulatory authority has announced its toll-free helpline: 0800-03727 for the masses to report any wrongdoing by drug stores as well as drug markets in regards to pricing as well as hoarding.
The availability of Actemra shot is being made certain anywhere as the medication authority takes due steps to suppress any kind of created rising cost of living as well as panic in the medicine market said DRAP in its announcement today as the Covid-19 pandemic continues to mar the health sector and economic situation.
Earlier this month, DRAP restricted physicians, through a circular, from composing trademark name of medicines in prescriptions.
“The physicians in their prescriptions ought to compose the generic formula of the medications,” the regulatory authority said in its advisory.
“The DRAP has actually made it unlawful for doctors to create the medicine’s supplier’s name in their prescriptions,” according to the round.
“It is a common technique that the exclusive, as well as government healthcare facilities’ medical professionals, compose the ‘trademark name’ of a medicine in their prescriptions with costly price.” “The individuals become loaded down to purchase expensive medications of a certain brand name,” the DRAP round read.